D-1167-2014 Class III Terminated

Recalled by McKesson Packaging Services — Concord, NC

FDA drug recall D-1167-2014 was initiated by McKesson Packaging Services on Mar 3, 2014 and is designated Class III. Reason for recall: Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval. The recall status is terminated (terminated Aug 14, 2014). Affected quantity: 1,557 Boxes.

Recall details

Product Type
Drugs
Report Date
Mar 26, 2014
Initiation Date
Mar 3, 2014
Termination Date
Aug 14, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,557 Boxes

Product description

Venlafaxine Hydrochloride, Extended Release Capsules, 150 mg, UD-100 Tablets per Box (10 x 10), Rx Only, Manufactured by: Teva Pharmaceuticals USA, 1090 Horsham Rd, North Wales, PA 19454, NDC 63739-0512-10

Reason for recall

Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.

Distribution pattern

Nationwide

Code information

Lot #: 91357

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1167-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1167-2014. Report a data issue: hello@regdatalab.com.